The concentration of sFasL, ICE and IL-1β in the serum and the liver tissue of chronic HCV infected patients

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1479-1483

  Lapinski, Tadeusz Wojciech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Antiviral therapy; Apoptosis; Chronic hepatitis C

Indexed keywords

FAS LIGAND; HEPATITIS C VIRUS RNA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; REBETRON; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ALCOHOL LIVER DISEASE; APOPTOSIS; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

CASPASE 1; DRUG COMBINATIONS; FAS LIGAND PROTEIN; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-1; LIVER; MEMBRANE GLYCOPROTEINS; RIBAVIRIN;

EID: 25844504659     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lau JY, Xie X, Lai MM, Wu PC: Apoptosis and viral hepatitis. Semin Liver Dis 1998; 18:169-176.
2. Scheuer PJ: Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991; 13:372-374.
3. Jiang Z, Liu Y, Savas L, Smith L, Bonkovsky H, Baker S, Banner B: Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases. Virchows Arch 1997; 431:189-194.
4. Kronenberger B, Ruster B, Lee JH, Sarrazin C, Roth WK, Herrmann G, Zeuzem S: Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. J Hepatol 2000; 33:640-647.
5. Tsutsui H, Matsui K, Okamura H, Nakanishi K: Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000; 174:192-209.
6. Rodrigues CM, Brites D, Serejo F, Costa A, Ramalho F, De Moura MC: Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis C patients. J Viral Hepat 2000; 7:175-183.
7. Farinati F, Cardin R, Florentine M, D'errico A, Grigioni W, Cecchetto A, Naccarato R: Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease. J Viral Hepat 2001; 8:34-40.
8. Calabrese F, Pontisso P, Pettenazzo E, Benvegnu L, Vario A, Chemello L, Alberti A: Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 2000; 31:1153-1159.
9. Hahn CS, Cho YG, Kang BS, Lester IM, Hahn YS: The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 2000; 276:127-137.
10. Marusawa H, Hijikata M, Chiba T, Shimotohno K: Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999; 73:4713-4720.
11. Pianko S, Patella S, Sievert W: Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection. J Gastroenterol Hepatol 2000; 15:798-805.
12. Kaser A, Enrich B, Ludwiczek O, Vogel W, Tilg H: Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perform pathway. Clin Exp Immunol 1999; 118:71-77.
13. Zhu N, Ware CF, Lai MM: Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology 2001; 283:178-187.
14. Abe S, Kotoh K, Arao S, Tabaru A, Otsuki M: Fas antigen expression on hepatocytes predicts the short- and long-term response to interferon therapy in patients with chronic hepatitis C. Scand J Gastroenterol 2001; 36:326-331.
15. Mita E, Hayashi N: Apoptosis in human diseases: role of Fas system in liver cell injury by viral hepatitis. Rinsho Byori 1997; 45:477-482.
16. Zhao J, Wang S, Xin S, Yi T, Liu P, Zhang L: Expression of CPP32, Fas and Fas ligand and the relationship between their expression and viral antigens in chronic hepatitis. Zhonghua Gan Zang Bing Za Zhi 2000; 8:233-235.
17. Di Martino V, Brenot C, Samuel D, Saurini F, Paradis V, Reynes M, Bismuth H: Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on Fas-mediated apoptosis after liver transplantation for hepatitis C. Transplantation 2000; 15:1390-1396.
18. Ghosh AK, Majumder M, Steele R, Meyer K, Ray R, Ray RB: Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res 2000; 67:173-178.
19. Ezelle HJ, Balacbandran S, Sicheri F, Polyak SJ, Barber GN: Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A. Virology 2001; 281:124-137.
20. Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K: Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. Virology 2000; 270:476-487.
21. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D: bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001; 112:364-369.
22. Yamanaka K, Tanaka M, Tsutsui H, Kupper TS, Asahi K, Okamura H, Nakanishi K: Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 2000; 165:997-1003.
23. Kisbihara Y, Hayashi J, Yoshimura E, Yamaji K, Nakashima K, Kasbiwagi S: IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Dig Dis Sci 1996; 41:315-321.
24. Piacentini M, Farrace MG, Hassan C, Serafini B, Autuori F: Tissue transglutaminase release from apoptotic cells into extracellular matrix during human liver fibrogenesis. J Pathol 1999; 189:92-98.